Dr. Jack West reviews clinical results in patients with advanced non-squamous NSCLC and high tumor PD-L1 on the KEYNOTE-189 trial, providing thoughts on the clinical implications of these findings in management of these patients.
KEYNOTE-189: Clinical Implications in Patients with Advanced Non-Squamous NSCLC and High (?50%) Tumor PD-L1 Expression (BMIC-031)
